Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01KOO
|
|||
Former ID |
DNC006641
|
|||
Drug Name |
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate
|
|||
Synonyms |
CHEMBL172215; (2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate; 103596-21-0; Sulfamic acid, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl ester; ACMC-20m6fs; SCHEMBL18063439; CTK0G6911; DTXSID50545931; BDBM50188393; Sulfamic acid 2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C6H13NO5S
|
|||
Canonical SMILES |
CC1(OCC(O1)COS(=O)(=O)N)C
|
|||
InChI |
1S/C6H13NO5S/c1-6(2)10-3-5(12-6)4-11-13(7,8)9/h5H,3-4H2,1-2H3,(H2,7,8,9)
|
|||
InChIKey |
QFFBTRPNKKXQCZ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 103596-21-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase II (CA-II) | Target Info | Inhibitor | [1] |
KEGG Pathway | Nitrogen metabolism | |||
Proximal tubule bicarbonate reclamation | ||||
Collecting duct acid secretion | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Bile secretion | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
EGFR1 Signaling Pathway | ||||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
Erythrocytes take up oxygen and release carbon dioxide | ||||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Reversible Hydration of Carbon Dioxide | |||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. J Med Chem. 2006 Jun 15;49(12):3496-500. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.